by
Thomas Dworetzky, Contributing Reporter | August 02, 2017
A new premium version of Aixplorer has been announced from French ultrasound company SuperSonic Imagine.
“Aixplorer Ultimate is the result of 8 years of research and development. This is a much more reliable, faster and innovative ultrasound system, designed to meet new imaging needs when screening, diagnosing and monitoring major diseases,” Jacques Souquet, co-founder and chief innovation officer at SuperSonic Imagine, said in a statement, adding that the technology has been “discussed in more than 400 publications.”
These studies, he added, had demonstrated that the technology in this system has “clinical advantages associated with the detection and characterization of many different diseases across a broad spectrum of applications.”
The Aixplorer Ultimate uses the company's UltraFast technology that's able to reach acquisition rates 200 times faster than conventional ultrasound systems.
Since 2009, the company has “been at the forefront of medical imaging with the Aixplorer ultrasound system and its revolutionary, software-only architecture,” SuperSonic Imagine CEO Michèle Lesieur said in a statement.
The architecture of the Aixplorer Ultimate has 4.5 times more computing power than earlier models, a new look and user interface.
It also has a new feature known as Needle PL.U.S (Planewave UltraSensitive), which allows for simultaneous visualization of anatomical structures, biopsy needles, and their trajectory with a high level of precision,” the company stated.
The Aixplorer Ultimate also comes with Supersonic's ShearWave Elastography, which can see and measure tissue stiffness in real time; UltraFast Doppler, a blend of pulsed and color doppler in a single sweep; Angio PL.U.S, with sufficiently high resolution to image microvascularisation in lesions; and TriVu, a new triplex modality that brings together three types of diagnostic information into one exam.
“These innovations provide fast and reliable access to diagnostic information, an essential resource for the diagnosis and assessment of major diseases such as chronic liver disease and breast and prostate cancers,” the company stressed.
In March, 2016, Supersonic Imagine showcased its ShearWave Elastography at ECR.
"Clinicians are eager for imaging advances and new tools to help identify and diagnose suspicious lesions while avoiding unnecessary imaging or biopsies," said Souquet at that time, noting that, "Angio PL.U.S. and our new 3-D endo transducer, combined with our existing innovations, SWE and UltraFast Doppler, represent significant advancements to the arsenal of noninvasive diagnostic tools for cancer or other major diseases."
SuperSonic Imagine had a good Q2
with 16 percent sales growth.
That's the fourth quarter in a row showing growth, which hit over 16 percent each quarter, according to a company statement.
Expressing pleasure at the second-quarter sales and saying that the continued growth gave the company “confidence in our projection for the rest of the year,” Lesieur said that “this overall great performance was driven by particularly buoyant growth in China (+41 percent), which is all the more important, given that China will become the world’s largest market by 2020, and in France (+32 percent).”
He also noted that the sales were not the only reason for the company's “improvement,” advising that the financial good news “was bolstered by sales of Aixplorer products, but even more so by our service activity, a consequence of the continual increase in our installed base.”
